This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Norman R. C. Campbell, MD

Arch Intern Med. 1996;156(15):1638-1644.

Abstract
Periconceptual use of folic acid supplements by women is effective in preventing neural tube defects in the fetus. Folic acid supplements also may prevent atherosclerosis and some malignant neoplasms. Nevertheless, safety concerns have delayed recommendations to increase folic acid consumption by the general population. Among the potential safety issues of folic acid supplementation are (1) difficulty identifying cobalamin deficiency, precipitation of neurologic complications of cobalamin deficiency, and lowering of cobalamin levels; (2) folate neurotoxicity; (3) antagonism of drugs that inhibit folate metabolism; (4) reduced zinc absorption; (5) association with malignant neoplasms; (6) hypersensitivity reactions; and (7) increased susceptibility to malaria. The data that suggest that folic acid supplements are unsafe are weak and consist predominantly of case series and reports. Nevertheless, greater difficulty diagnosing cobalamin deficiency due to "masking" of hematologic abnormalities by folic acid is a potential risk. Strict vegetarians need to be informed that they are at risk of cobalamin deficiency. Physicians need to be aware that routine hematologic indexes have a low sensitivity for cobalamin deficiency, especially in patients who are receiving folic acid supplements. Because no high-quality data exclude specific adverse effects, physicians should be vigilant in identifying detrimental effects when patients increase their consumption of folic acid.

Arch Intern Med. 1996;156:1638-1644

Author Affiliations
From the Divisions of General Internal Medicine and Geriatrics, Departments of Medicine and Pharmacology and Therapeutics, Faculty of Medicine, The University of Calgary, Alberta.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vegetarian Diets in Children and Adolescents
Renda and Fischer
Pediatr. Rev. 2009;30:e1-e8.
FULL TEXT  

Folic Acid Supplementation and Cancer Risk: Point
Kim
Cancer Epidemiol. Biomarkers Prev. 2008;17:2220-2225.
FULL TEXT  

Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Moens et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1971-H1977.
ABSTRACT | FULL TEXT  

Folate: a magic bullet or a double edged sword for colorectal cancer prevention?
Kim
Gut 2006;55:1387-1389.
FULL TEXT  

A Randomized, Controlled Trial of the Effects of Adding Vitamin B12 and Folate to Erythropoietin for the Treatment of Anemia of Prematurity
Haiden et al.
Pediatrics 2006;118:180-188.
ABSTRACT | FULL TEXT  

Predicting bioavailable zinc from lower phytate forms, folic Acid and their interactions with zinc in vegetarian meals.
Chiplonkar and Agte
J. Am. Coll. Nutr. 2006;25:26-33.
ABSTRACT | FULL TEXT  

Effects of dietary folate on the development and progression of mammary tumors in rats
Kotsopoulos et al.
Carcinogenesis 2005;26:1603-1612.
ABSTRACT | FULL TEXT  

Will mandatory folic acid fortification prevent or promote cancer?
Kim
Am. J. Clin. Nutr. 2004;80:1123-1128.
ABSTRACT | FULL TEXT  

Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
Bleie et al.
Am. J. Clin. Nutr. 2004;80:641-648.
ABSTRACT | FULL TEXT  

Role of Folate in Colon Cancer Development and Progression
Kim
J. Nutr. 2003;133:3731S-3739.
ABSTRACT | FULL TEXT  

Dietary folate deficiency suppresses N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats
Kotsopoulos et al.
Carcinogenesis 2003;24:937-944.
ABSTRACT | FULL TEXT  

News and Views on Folate and Elderly Persons
Lokk
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M354-361.
ABSTRACT | FULL TEXT  

Folates and Cardiovascular Disease
Verhaar et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:6-13.
ABSTRACT | FULL TEXT  

Potential Clinical and Economic Effects of Homocyst(e)ine Lowering
Nallamothu et al.
Arch Intern Med 2000;160:3406-3412.
ABSTRACT | FULL TEXT  

Homocysteine and Neurologic Disease
Diaz-Arrastia
Arch Neurol 2000;57:1422-1427.
ABSTRACT | FULL TEXT  

Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial
Brouwer et al.
Am. J. Clin. Nutr. 1999;69:99-104.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment
Stein and McBride
Arch Intern Med 1998;158:1301-1306.
ABSTRACT | FULL TEXT  

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration
BMJ 1998;316:894-898.
ABSTRACT | FULL TEXT  

Interrelated Risk Factors for Venous Thromboembolism
Phillips
Circulation 1997;95:1749-1751.
FULL TEXT